PMDA drug package insert
コミナティRTU筋注5～11歳用1人用
PMDA Prescription drug · ファイザー株式会社 · package insert Aug 31, 2026
Key facts
| Brand names | コミナティRTU筋注5～11歳用1人用 |
|---|---|
| Nonproprietary names | コロナウイルス（ＳＡＲＳ－ＣｏＶ－２）ＲＮＡワクチン |
| Companies | 製造販売元／ファイザー株式会社, 技術提携／BIONTECH |
| Product type | Prescription drug |
| Therapeutic category | ウイルスワクチン類 |
| Therapeutic category codes | 876313 |
| YJ codes | 631341DA9026 |
| Approval numbers | 30600AMX00136 |
| Package insert edition | 第4版 |
| Package insert date | Aug 31, 2026 |
| PMDA document key | 672212_631341DA9026_1 |
| PMDA company code | 672212 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: